<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Patents, business methods, and the requirement(?) that the claimed invention relate to a &#8216;field of technology&#8217;</title>
	<atom:link href="http://www.lawfont.com/2005/10/15/patents-business-methods-and-the-requirement-that-the-claimed-invention-relate-to-a-field-of-technology/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.lawfont.com/2005/10/15/patents-business-methods-and-the-requirement-that-the-claimed-invention-relate-to-a-field-of-technology/</link>
	<description>an analysis of law, technology, economics, and policy</description>
	<lastBuildDate>Thu, 29 Dec 2011 19:59:43 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
	<item>
		<title>By: LawFont &#187; Upcoming Attractions in Australian IP&#8230;some developments to expect in 2006</title>
		<link>http://www.lawfont.com/2005/10/15/patents-business-methods-and-the-requirement-that-the-claimed-invention-relate-to-a-field-of-technology/comment-page-1/#comment-76</link>
		<dc:creator>LawFont &#187; Upcoming Attractions in Australian IP&#8230;some developments to expect in 2006</dc:creator>
		<pubDate>Sat, 07 Jan 2006 04:48:37 +0000</pubDate>
		<guid isPermaLink="false">http://www.lawfont.com/?p=73#comment-76</guid>
		<description>[...] The second is the continuing debate over business method patents. The scope of what is patentable in this context is a matter of live debate here in Australia at the moment; a debate only likely to be enlivened when the issue hits the Full Federal Court this February. The case of Grant v Commissioner of Patents is listed for hearing before Heerey, Kiefel and Bennett JJ on 28 February 2006. Readers might recall I&#8217;ve discussed this case before in some detail - see here and here. Warwick Rothnie also has a discussion here. Some practitioners have criticised IP Australia&#8217;s, and the Court&#8217;s approach as being &#8217;short-sighted&#8217; - see for example the passage from Clark quoted in this post. [...]</description>
		<content:encoded><![CDATA[<p>[...] The second is the continuing debate over business method patents. The scope of what is patentable in this context is a matter of live debate here in Australia at the moment; a debate only likely to be enlivened when the issue hits the Full Federal Court this February. The case of Grant v Commissioner of Patents is listed for hearing before Heerey, Kiefel and Bennett JJ on 28 February 2006. Readers might recall I&#8217;ve discussed this case before in some detail &#8211; see here and here. Warwick Rothnie also has a discussion here. Some practitioners have criticised IP Australia&#8217;s, and the Court&#8217;s approach as being &#8217;short-sighted&#8217; &#8211; see for example the passage from Clark quoted in this post. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: LawFont &#187; Cert granted in LabCorp v. Metabolite</title>
		<link>http://www.lawfont.com/2005/10/15/patents-business-methods-and-the-requirement-that-the-claimed-invention-relate-to-a-field-of-technology/comment-page-1/#comment-48</link>
		<dc:creator>LawFont &#187; Cert granted in LabCorp v. Metabolite</dc:creator>
		<pubDate>Mon, 31 Oct 2005 23:20:24 +0000</pubDate>
		<guid isPermaLink="false">http://www.lawfont.com/?p=73#comment-48</guid>
		<description>[...] On Monday, the US Supreme Court granted certiorari (equivalent to the Australian High Court granting special leave) in a patent case, LabCorp v. Metabolite. The case is about patentability of medical processes, and has the potential, according to the Patently-O Blog, of addressing some of the &#8216;patentability of processes&#8217; issues raised in the Ex p Lundgren case that I&#8217;ve commented on before (here and here). [...]</description>
		<content:encoded><![CDATA[<p>[...] On Monday, the US Supreme Court granted certiorari (equivalent to the Australian High Court granting special leave) in a patent case, LabCorp v. Metabolite. The case is about patentability of medical processes, and has the potential, according to the Patently-O Blog, of addressing some of the &#8216;patentability of processes&#8217; issues raised in the Ex p Lundgren case that I&#8217;ve commented on before (here and here). [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: LawFont &#187; Business Method Patents in the US - more developments</title>
		<link>http://www.lawfont.com/2005/10/15/patents-business-methods-and-the-requirement-that-the-claimed-invention-relate-to-a-field-of-technology/comment-page-1/#comment-46</link>
		<dc:creator>LawFont &#187; Business Method Patents in the US - more developments</dc:creator>
		<pubDate>Fri, 28 Oct 2005 02:38:39 +0000</pubDate>
		<guid isPermaLink="false">http://www.lawfont.com/?p=73#comment-46</guid>
		<description>[...] A little while ago I blogged about Ex parte Carl A. Lundgren, a decision of the Board of Patent Appeals and Interferences of the US Patent and Trade Mark Office (USPTO). In that decision, the Board overturned the Examiner&#8217;s objection to the patent, holding there is no separate â€œtechnological artsâ€ test in determining whether a process is statutory subject matter. The decision potentially broadened the patentability of what you might call &#8216;pure business methods&#8217; - those not instantiated in &#8216;technology&#8217; (like software or hardware). [...]</description>
		<content:encoded><![CDATA[<p>[...] A little while ago I blogged about Ex parte Carl A. Lundgren, a decision of the Board of Patent Appeals and Interferences of the US Patent and Trade Mark Office (USPTO). In that decision, the Board overturned the Examiner&#8217;s objection to the patent, holding there is no separate â€œtechnological artsâ€ test in determining whether a process is statutory subject matter. The decision potentially broadened the patentability of what you might call &#8216;pure business methods&#8217; &#8211; those not instantiated in &#8216;technology&#8217; (like software or hardware). [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

